0001683607-26-000002.txt : 20260102 0001683607-26-000002.hdr.sgml : 20260102 20260102160643 ACCESSION NUMBER: 0001683607-26-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20251231 FILED AS OF DATE: 20260102 DATE AS OF CHANGE: 20260102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bassler Bonnie L CENTRAL INDEX KEY: 0001683607 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39329 FILM NUMBER: 26502423 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Royalty Pharma plc CENTRAL INDEX KEY: 0001802768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 4 1 wk-form4_1767388000.xml FORM 4 X0508 4 2025-12-31 0 0001802768 Royalty Pharma plc RPRX 0001683607 Bassler Bonnie L C/O ROYALTY PHARMA PLC 110 E. 59TH STREET NEW YORK NY 10022 1 0 0 0 0 Class A Ordinary Shares 2025-12-31 4 A 0 967 38.7418 A 73132 D Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500. /s/ Sean Weisberg, as Attorney-in-Fact for Bonnie L. Bassler 2026-01-02